Effect of hormone therapy on the elastic properties of the arteries in healthy postmenopausal women

Journal of Endocrinological Investigation

Volumn 28, Issue 6, 2005, Pages 305-311

  Tentolouris, N ^a   Christodoulakos, G ^b,c   Lambrinoudaki, I ^b   Mandalaki, E ^a   Panoulis, C ^b   Maridaki, C ^a   Creatsas, G ^b   Katsilambros, N ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Aortic pressure; Estrogen; Hormone therapy; Pulse wave analysis

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CONJUGATED ESTROGEN; CONTRACEPTIVE AGENT; MEDROXYPROGESTERONE ACETATE;

ADULT; AORTA PRESSURE; ARTERY; ARTICLE; CONTROLLED STUDY; ELASTICITY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PULSE WAVE; SYSTOLE; TONOMETRY; AORTA; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HORMONE SUBSTITUTION; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; VASCULAR RESISTANCE;

AORTA; ARTERIES; BLOOD PRESSURE; CONTRACEPTIVE AGENTS, FEMALE; ELASTICITY; ESTROGENS, CONJUGATED (USP); FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; VASCULAR RESISTANCE;

EID: 23444452251     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03347195     Document Type: Article

References (47)

1. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Practice, 3rd ed. London: Arnold. 1990.
2. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 1994, 140: 669-82.
3. Safar ME, London GM, Asmar R, Frohlich ED. Recent advances on large arteries in hypertension. Hypertension 1998, 32: 156-61.
4. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997, 95: 252-64.
5. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990, 81: 1680-7.
6. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999, 103: 401-6.
7. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994, 89: 1943-50.
8. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991, 265: 1861-7.
9. Grady D, Herrington D, Bittner V, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002, 288: 49-57.
10. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for the Womens Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288: 321-33.
11. Barrett-Connor E. Clinical review 162: cardiovascular endocrinology: an epidemiologist looks at hormomes and heart disease in women. J Clin Endocrinol Metab 2003, 88: 4031-42.
12. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 2002, 16: 509-16.
13. Teede HJ, Liang YL, Kotsopoulos D, Zoungas S, Craven R, McGrath BP. A placebo-controlled trial of long-term combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin Endocrinol (Oxf) 2001, 55: 673-82.
14. Mares P, Dauzat M, Abramovici Y. Hormone replacement therapy with estradiol valerate and cyproterone acetate: effects on endothelium-dependent vasodilatation and arterial wall compliance. Maturitas 2002, 42: 45-53.
15. Waddell TK, Rajkumar C, Cameron JD, Jennings GL, Dart AM, Kingwell BA. Withdrawal of hormonal therapy for 4 weeks decreases arterial compliance in postmenopausal women. J Hypertens 1999, 17: 413-8.
16. Hayward CS, Knight DC, Wren BG, Kelly RP. Effect of hormone replacement therapy on non-invasive cardiovascular haemodynamics. J Hypertens 1997, 15: 987-93.
17. De Leo V, la Marca A, Orlandi R, Crippa D, Setacci C, Petraglia F. Effects of estradiol alone or in combination with cyproterone acetate on carotid artery pulsatility index in postmenopausal women. Maturitas 2003, 46: 219-24.
18. Hayward CS, Kalnins WV, Kelly RP. Acute effects of 17beta-estradiol on ventricular and vascular hemodynamics in postmenopausal women. Am J Physiol Heart Circ Physiol 2000, 279: H2277-84.
19. Stefanadis C, Tsiamis E, Dernellis J, Toutouzas P. Effect of estrogen on aortic function in postmenopausal women. Am J Physiol Heart Circ Physiol 1999, 276: H658-62.
20. O'Rourke MF, Gallagher DE. Pulse wave analysis. J Hypertens 1996, 14 (Suppl): S147-57.
21. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001, 38: 434-8.
22. Ubels FL, Muntinga JH, van Doormaal JJ, Reitsma WD, Smit AJ. Effects of initial and long-term lipid-lowering therapy on vascular wall characteristics. Atherosclerosis 2001, 154: 155-61.
23. Christodoulakos GE, Lambrinoudaki IV, Panoulis KP, et al. The effect of various regimens of hormone replacement therapy on mammographic breast density. Maturitas 2003, 45: 109-18.
24. Westerbacka J, Wilkinson I, Cockcroft J, Utriainen T, Vehkavaara S, Yki-Jarvinen H. Diminished wave reflection in the aorta. A novel physiological action of insulin on large blood vessels. Hypertension 1999, 33: 1118-22.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18: 499-502.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9.
27. Staessen JA, van der Heijden-Spek JJ, Safar ME, et al. Menopause and the characteristics of the large arteries in a population study. J Hum Hypertens 2001, 15: 511-8.
28. Cameron JD, Bulpitt CJ, Pinto ES, Rajkumar C. The aging of elastic and muscular arteries: a comparison of diabetic and nondiabetic subjects. Diabetes Care 2003, 26: 2133-8.
29. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 2002, 106: 2085-90.
30. Laurent S, Boutouyrie P, Gautier L, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37: 1236-41.
31. Gorgulu S, Eren M, Celik S, et al. The effects of hormonal therapy on aortic stiffness and left ventricular diastolic function. Acta Cardiol 2003, 58: 1-8.
32. Miura S, Tanaka E, Mori A, et al. Hormone replacement therapy improves arterial stiffness in normotensive post-menopausal women. Maturitas 2003, 45: 293-8.
33. Scuteri A, Lakatta EG, Bos AJ, Fleg JL. Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women. Aging (Milano) 2001, 13: 122-30.
34. Tatchum-Talom R, Martel C, Marette A. Influence of estrogen on aortic stiffness and endothelial function in female rats. Am J Physiol Heart Circ Physiol 2002, 282: H491-8.
35. Kelly RP, Gibbs HH, O'Rourke MF, et al. Nitroglycerine has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990, 11: 138-44.
36. Edouard DA, Pannier BM, London GM, Cuche JL, Safar ME. Venous and arterial behavior during normal pregnancy. Am J Physiol Heart Circ Physiol 1998, 274: H1605-12.
37. Stevenson JC. Cardiovascular effects of estrogens. J Steroid Biochem Mol Biol 2000, 74: 387-93.
38. Walsh BW, Kuller LH, Wild RA, et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 1998, 279: 1445-51.
39. Walsh BW, Paul S, Wild RA, et al. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized controlled trial. J Clin Endocrinol Metab 2000, 85: 214-8.
40. Christodoulakos G, Lambrinoudaki I, Panoulis C, Rizos D, Coutoukos J, Creatsas G. Effect of raloxifene, estrogen, and hormone replacement therapy on serum homocysteine levels in postmenopausal women. Fertil Steril 2003, 79: 455-6.
41. Cushman M. Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation. Am J Cardiol 2002, 90: 7-10F.
42. Christodoulakos G, Panoulis C, Kouskouni E, Chondros C, Dendrinos S, Creatsas G. Effects of estrogen - progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis. Gynecol Endocrinol 2002, 16: 9-17.
43. Rahimian R, Laher I, Dube G, van Breeman C. Estrogen and selective estrogen receptor modulator LY 117018 enhance release of nitric oxide in ref aorta. J Pharmacol Exp Ther 1997, 283: 116-22.
44. Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 2003, 41: 183-7.
45. Mahmud A, Feely J. Effects of passive smoking on blood pressure and aortic pressure waveform in healthy young adults-influence of gender. Br J Clin Pharmacol 2004, 57: 37-43.
46. Angerer P, Kothny W, Stork S, von Schacky C. Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial. J Am Coll Cardiol 2000, 36: 1789-96.
47. Girdler SS, Hinderliter AL, Wells EC, Sherwood A, Grewen KM, Light KC. Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects. Obstet Gynecol 2004, 103: 169-80.